Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors

Scott C. Davis, Kimberley S. Samkoe, Julia A. O'Hara, Summer Gibbs, Keith D. Paulsen, Brian W. Pogue

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Fluorescence molecular tomography (FMT) systems coupled to conventional imaging modalities such as magnetic resonance imaging (MRI) and computed tomography provide unique opportunities to combine data sets and improve image quality and content. Yet, the ideal approach to combine these complementary data is still not obvious. This preclinical study compares several methods for incorporating MRI spatial prior information into FMT imaging algorithms in the context of in vivo tissue diagnosis. Populations of mice inoculated with brain tumors that expressed either high or low levels of epidermal growth factor receptor (EGFR) were imaged using an EGF-bound near-infrared dye and a spectrometer-based MRI-FMT scanner. All data were spectrally unmixed to extract the dye fluorescence from the tissue autofluorescence. Methods to combine the two data sets were compared using student's t-tests and receiver operating characteristic analysis. Bulk fluorescence measurements that made up the optical imaging data set were also considered in the comparison. While most techniques were able to distinguish EGFR(+) tumors from EGFR(-) tumors and control animals, with area-under-the-curve values=1, only a handful were able to distinguish EGFR(-) tumors from controls. Bulk fluorescence spectroscopy techniques performed as well as most imaging techniques, suggesting that complex imaging algorithms may be unnecessary to diagnose EGFR status in these tissue volumes.

Original languageEnglish (US)
Article number051602
JournalJournal of Biomedical Optics
Volume15
Issue number5
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

Magnetic resonance
brain
Tomography
magnetic resonance
Tumors
Brain
tumors
tomography
Fluorescence
Imaging techniques
fluorescence
Epidermal Growth Factor Receptor
Tissue
dyes
Coloring Agents
Dyes
imaging techniques
students
scanners
mice

Keywords

  • Biomedical optics
  • Fluorescence spectroscopy
  • Image reconstruction
  • Magnetic resonance imaging
  • Tomography

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Electronic, Optical and Magnetic Materials
  • Atomic and Molecular Physics, and Optics

Cite this

Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors. / Davis, Scott C.; Samkoe, Kimberley S.; O'Hara, Julia A.; Gibbs, Summer; Paulsen, Keith D.; Pogue, Brian W.

In: Journal of Biomedical Optics, Vol. 15, No. 5, 051602, 09.2010.

Research output: Contribution to journalArticle

Davis, Scott C. ; Samkoe, Kimberley S. ; O'Hara, Julia A. ; Gibbs, Summer ; Paulsen, Keith D. ; Pogue, Brian W. / Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors. In: Journal of Biomedical Optics. 2010 ; Vol. 15, No. 5.
@article{ccfeef2f245c4839b8ee5887adad7eb7,
title = "Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors",
abstract = "Fluorescence molecular tomography (FMT) systems coupled to conventional imaging modalities such as magnetic resonance imaging (MRI) and computed tomography provide unique opportunities to combine data sets and improve image quality and content. Yet, the ideal approach to combine these complementary data is still not obvious. This preclinical study compares several methods for incorporating MRI spatial prior information into FMT imaging algorithms in the context of in vivo tissue diagnosis. Populations of mice inoculated with brain tumors that expressed either high or low levels of epidermal growth factor receptor (EGFR) were imaged using an EGF-bound near-infrared dye and a spectrometer-based MRI-FMT scanner. All data were spectrally unmixed to extract the dye fluorescence from the tissue autofluorescence. Methods to combine the two data sets were compared using student's t-tests and receiver operating characteristic analysis. Bulk fluorescence measurements that made up the optical imaging data set were also considered in the comparison. While most techniques were able to distinguish EGFR(+) tumors from EGFR(-) tumors and control animals, with area-under-the-curve values=1, only a handful were able to distinguish EGFR(-) tumors from controls. Bulk fluorescence spectroscopy techniques performed as well as most imaging techniques, suggesting that complex imaging algorithms may be unnecessary to diagnose EGFR status in these tissue volumes.",
keywords = "Biomedical optics, Fluorescence spectroscopy, Image reconstruction, Magnetic resonance imaging, Tomography",
author = "Davis, {Scott C.} and Samkoe, {Kimberley S.} and O'Hara, {Julia A.} and Summer Gibbs and Paulsen, {Keith D.} and Pogue, {Brian W.}",
year = "2010",
month = "9",
doi = "10.1117/1.3483902",
language = "English (US)",
volume = "15",
journal = "Journal of Biomedical Optics",
issn = "1083-3668",
publisher = "SPIE",
number = "5",

}

TY - JOUR

T1 - Comparing implementations of magnetic-resonance-guided fluorescence molecular tomography for diagnostic classification of brain tumors

AU - Davis, Scott C.

AU - Samkoe, Kimberley S.

AU - O'Hara, Julia A.

AU - Gibbs, Summer

AU - Paulsen, Keith D.

AU - Pogue, Brian W.

PY - 2010/9

Y1 - 2010/9

N2 - Fluorescence molecular tomography (FMT) systems coupled to conventional imaging modalities such as magnetic resonance imaging (MRI) and computed tomography provide unique opportunities to combine data sets and improve image quality and content. Yet, the ideal approach to combine these complementary data is still not obvious. This preclinical study compares several methods for incorporating MRI spatial prior information into FMT imaging algorithms in the context of in vivo tissue diagnosis. Populations of mice inoculated with brain tumors that expressed either high or low levels of epidermal growth factor receptor (EGFR) were imaged using an EGF-bound near-infrared dye and a spectrometer-based MRI-FMT scanner. All data were spectrally unmixed to extract the dye fluorescence from the tissue autofluorescence. Methods to combine the two data sets were compared using student's t-tests and receiver operating characteristic analysis. Bulk fluorescence measurements that made up the optical imaging data set were also considered in the comparison. While most techniques were able to distinguish EGFR(+) tumors from EGFR(-) tumors and control animals, with area-under-the-curve values=1, only a handful were able to distinguish EGFR(-) tumors from controls. Bulk fluorescence spectroscopy techniques performed as well as most imaging techniques, suggesting that complex imaging algorithms may be unnecessary to diagnose EGFR status in these tissue volumes.

AB - Fluorescence molecular tomography (FMT) systems coupled to conventional imaging modalities such as magnetic resonance imaging (MRI) and computed tomography provide unique opportunities to combine data sets and improve image quality and content. Yet, the ideal approach to combine these complementary data is still not obvious. This preclinical study compares several methods for incorporating MRI spatial prior information into FMT imaging algorithms in the context of in vivo tissue diagnosis. Populations of mice inoculated with brain tumors that expressed either high or low levels of epidermal growth factor receptor (EGFR) were imaged using an EGF-bound near-infrared dye and a spectrometer-based MRI-FMT scanner. All data were spectrally unmixed to extract the dye fluorescence from the tissue autofluorescence. Methods to combine the two data sets were compared using student's t-tests and receiver operating characteristic analysis. Bulk fluorescence measurements that made up the optical imaging data set were also considered in the comparison. While most techniques were able to distinguish EGFR(+) tumors from EGFR(-) tumors and control animals, with area-under-the-curve values=1, only a handful were able to distinguish EGFR(-) tumors from controls. Bulk fluorescence spectroscopy techniques performed as well as most imaging techniques, suggesting that complex imaging algorithms may be unnecessary to diagnose EGFR status in these tissue volumes.

KW - Biomedical optics

KW - Fluorescence spectroscopy

KW - Image reconstruction

KW - Magnetic resonance imaging

KW - Tomography

UR - http://www.scopus.com/inward/record.url?scp=79952520478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952520478&partnerID=8YFLogxK

U2 - 10.1117/1.3483902

DO - 10.1117/1.3483902

M3 - Article

C2 - 21054076

AN - SCOPUS:79952520478

VL - 15

JO - Journal of Biomedical Optics

JF - Journal of Biomedical Optics

SN - 1083-3668

IS - 5

M1 - 051602

ER -